Anabelle Colaco
01 Aug 2025, 09:10 GMT+10
WASHINGTON, D.C.: Vinay Prasad, the chief medical and science officer at the U.S. Food and Drug Administration (FDA), has left the agency, according to the U.S. Department of Health and Human Services (HHS), which confirmed his departure.
"Dr. Prasad did not want to be a distraction to the great work of the FDA in the Trump administration and has decided to return to California and spend more time with his family," an HHS spokesperson said in an emailed statement to Reuters. "We thank him for his service and the many important reforms he was able to achieve in his time at the FDA."
His resignation follows a series of controversial decisions involving the FDA's handling of Elevidys, a gene therapy developed by Sarepta Therapeutics for Duchenne muscular dystrophy. The agency initially paused distribution of the treatment after the deaths of several patients but reversed the suspension earlier this week.
STAT News was the first to report Prasad's departure. The outlet previously noted in June that Prasad had been named to the FDA's top science post, citing an internal memo.
In May, Prasad, an oncologist known for publicly criticizing FDA leadership and COVID-19 policies, was also appointed director of the FDA's Center for Biologics Evaluation and Research.
Get a daily dose of Africa Leader news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Africa Leader.
More InformationIn an extraordinary outburst, U.S. President Donald Trump, aside from lambasting Federal Reserve Cahir Jay Powell, has now taken aim...
NEW DELHI, India: Three suspected militants killed in a July 28 gunbattle near Srinagar were behind the deadly Pahalgam attack that...
MADRID, Spain: Spain is set to expand its paid parental leave policy, granting new fathers and mothers an additional week of time off...
The Trump administration moved Thursday to deny visas to Palestinian officials, accusing them of sabotaging peace efforts, a stark...
MOSCOW, Russia: One of the most powerful earthquakes ever recorded — measuring 8.8 in magnitude — struck off the remote coast of Russia's...
WASHINGTON, D.C.: Vinay Prasad, the chief medical and science officer at the U.S. Food and Drug Administration (FDA), has left the...
NEW YORK, New York - The latest jobs report, coupled with the disclosure of President Donald Trump's new tariffs rattled stock markets...
WASHINGTON, D.C.: President Donald Trump's tariff policy is now taking effect, and many companies are signaling who will absorb the...
PARIS/NEW YORK: Luxury brands are walking a tightrope in the U.S. after fresh tariffs threatened to squeeze profits at a time when...
BEIJING/SHANGHAI/NEW YORK: Nvidia has placed an order for 300,000 more H20 chips with contract manufacturer TSMC, two sources told...
NEW YORK, New York - U.S. and global stocks weakened on Thursday, led by declines in the tech sector. These market reactions—despite...
CHEYENNE, Wyoming: A new AI data center planned near Cheyenne, Wyoming, is set to consume more electricity than all the state's homes...